Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12618001378213
ACTRN12618001378213
Not yet recruiting
Not Applicable

Detection of taxane-induced neuropathy using patient-reported outcomes

Royal Adelaide Hospital0 sites100 target enrollmentAugust 16, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsBreast cancerPeripheral neuropathy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast cancer
Sponsor
Royal Adelaide Hospital
Enrollment
100
Status
Not yet recruiting
Last Updated
7 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 16, 2018
End Date
TBD
Last Updated
7 years ago
Study Type
Observational
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Early Detection of Taxane-Induced Neuropathy in Women With Breast CancerPeripheral Neuropathy
NCT02549534Indiana University29
Completed
Not Applicable
Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast CancerPeripheral NeuropathyStage 0 Breast CancerStage I Breast CancerStage IA Breast CancerStage IB Breast CancerStage II Breast CancerStage IIA Breast CancerStage IIB Breast CancerStage III Breast CancerStage IIIA Breast CancerStage IIIB Breast CancerStage IIIC Breast CancerStage IV Breast Cancer
NCT03139435Wake Forest University Health Sciences20
Completed
Not Applicable
Pre-study to Evaluate IENFD Induction in Patients With Taxane-induced CIPNPeripheral Nervous System Diseases
NCT05133947Beijing 3E-Regenacy Pharmaceuticals Co., Ltd.24
Active, not recruiting
Phase 2
The Effect of Acupuncture on Nerve Pain Caused by Taxane (Chemotherapy) TreatmentBreast CancerTaxane-Induced Peripheral Neuropathy
NCT05458284Memorial Sloan Kettering Cancer Center80
Active, not recruiting
Phase 2
Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast CancerPrognostic Stage IIIC Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Invasive Breast CarcinomaPrognostic Stage I Breast Cancer AJCC v8Prognostic Stage IA Breast Cancer AJCC v8Prognostic Stage IB Breast Cancer AJCC v8Prognostic Stage II Breast Cancer AJCC v8Prognostic Stage IIA Breast Cancer AJCC v8Prognostic Stage IIB Breast Cancer AJCC v8Prognostic Stage III Breast Cancer AJCC v8Prognostic Stage IIIA Breast Cancer AJCC v8Prognostic Stage IIIB Breast Cancer AJCC v8
NCT04001829ECOG-ACRIN Cancer Research Group249